The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute is the Midwest’s first freestanding cancer hospital and the nation’s third largest, offering advanced inpatient and outpatient care via over 200 cancer specialists. As an NCI-designated comprehensive cancer center since 1976, the center is among the select few conducting phase I and II trials on NCI-provided anticancer agents. Recently, it introduced central Ohio’s first proton therapy gantry, equipped for groundbreaking FLASH therapy, positioning the center as a leader in clinical trials for emerging treatments. Renowned for sarcoma care, the center attracts patients globally and innovates in fields such as AI-driven cancer diagnostics and cell-based immunotherapies for lung cancer. The center boasts $76 million in NCI grants and a record $134 million in total cancer research funding in 2023.
Back to list

Becker's Recognition
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (Columbus)has been named a Becker's honoree on the lists below.
2024 Winner

Hospital & Health Systems
Hospital and Health Systems With Great Oncology Programs
These organizations have earned national recognition for their work in cancer care. These programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.
Oncology
